You have full text access to this Open Access content

Pharmacology Research & Perspectives

Articles are published under the terms of the Creative Commons License as stated in the final article.

Cover image for Vol. 4 Issue 6

Editors: Darrell R. Abernethy & Andrew J. Lawrence

Online ISSN: 2052-1707

Associated Title(s): British Journal of Clinical Pharmacology, British Journal of Pharmacology

Recently Published Issues

See all

Meet the Editors

Vid buttonSee the New Editors discuss PR&P and its futureshort 6 minute video.

Darrell AbernethyEditor in Chief: Darrell Abernethy
Darrell is Professor of Medicine and Pharmacology and Molecular Science (part-time), Johns Hopkins Univ. School of Medicine. He received his M.D. (AOA) and Ph.D. (Pharmacology) degrees from the University of Kansas School of Medicine. Dr. Abernethy is an experienced editor. He served as Editor-in-Chief of Pharmacological Reviews and as an Associate Editor of the Journal of Pharmacology and Experimental Therapeutics among other positions. He has contributed to the understanding of mechanisms of peripheral distribution of drugs and drug disposition and effect in obesity.

Andrew LawrenceDeputy Editor: Andrew Lawrence
As well as being a BPS Fellow, Professor Andrew Lawrence is head of the Behavioural Neuroscience Division at the Florey, overseeing 50 researchers. His primary research interest is in the development of robust animal models of drug-seeking, drug-taking and drug-induced neural adaptation. He has published over 150 original articles and has sat on a number of editorial boards, including his current role as Reviews Editor of The British Journal of Pharmacology. He is also the President of the Asian-Pacific Society for Neurochemistry.

See More

Open for submissions

Submit now!


Pharmacology Research & Perspectives has now been accepted for indexing in PubMed Central (PMC).

Pharmacology Research & Perspectives invites authors to submit research articles and invites submission of several types of special articles. These are:
1. Target validation – publication of negative findings including preclinical papers that show a hypothesis is incorrect or papers on drugs that have failed in early clinical development
2. Drug discovery reviews – strategy, hypotheses and data resulting in a successful therapeutic drug
3. Frontiers in translational medicine – drug and target validation for an unmet therapeutic need
4. Pharmacological hypotheses – reviews that are oriented to inform a novel hypothesis
5. Replication studies - work that refutes key findings (failed replication), and work that validates key findings
Read more about PR&P's support for the publication of negative findings.

PR&P authors benefit from:
• Rapid peer review
• Full compliance with all open access mandates
• Authors retain copyright and articles are published under a Creative Commons License
• Discounts for ASPET and BPS society members and authors at institutions with Wiley accounts

Submit a manuscript >

Supported by ASPET and BPS Journals

Supported by ASPET and BPS Journals

The following journals published by ASPET and BPS participate in a Manuscript Transfer Program by referring selected articles of suitable quality and offering authors the option to have their paper, with any peer review reports, automatically transferred to Pharmacology Research & Perspectives. We also, of course, encourage direct submission of articles.

 The Journal of Pharmacology and Experimental Therapeutics British Journal of Pharmacology
  The Journal of Pharmacology and Experimental Therapeutics  British Journal of Pharmacology
 Molecular Pharmacology British Journal of Clinical Pharmacology
  Molecular Pharmacology  British Journal of Clinical Pharmacology
 Drug Metabolism and Disposition 
  Drug Metabolism and Disposition